Quantcast

Keystone Today

Tuesday, December 3, 2024

FDA conducted lowest number of inspections on Drugs companies in Pennsylvania during Q2

Webp ishuwpt6uyanzpnvvfpnzrwi0yoq

Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website

Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website

In the second quarter of 2024, two Drugs companies received two FDA inspections in Pennsylvania, according to the U.S. Food and Drug Administration (FDA).

This was the lowest number of inspections per type of company made by the FDA in Pennsylvania, equalling 6.5% of all inspections in the second quarter of 2024.

Of all the Pennsylvania companies involved in the Drugs sector, Pace Analytical Services received the most citations from the FDA in the second quarter of 2024.

The FDA routinely inspects facilities across the nation to determine if the workplaces and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly for businesses to consistently make smarter business decisions for the future.

The FDA is a government agency primarily responsible for monitoring the manufacturing and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.

FDA Inspections in Pennsylvania During Q2
Project AreaNo Action IndicatedVoluntary Action IndicatedOfficial Action Indicated
Bioresearch Monitoring1----
Blood and Blood Products8----
Compliance: Devices2----
Drug Quality Assurance--1--
Food Composition, Standards, Labeling and Econ2----
Foodborne Biological Hazards124--
Human Cellular, Tissue, and Gene Therapies11--
Monitoring of Marketed Animal Drugs, Feed, and Devices11--
Postmarket Assurance: Devices11--

MORE NEWS